Background. Radiation recall refers to a tissue reaction produced by a chemotherapeutic agent in a previously irradiated field that would not occur in a nonirradiated field. A number of agents have been reported to cause radiation recall. Recently, there have been case reports of recall dermatitis from paclitaxel treatment. Methods. A patient with metastatic lung cancer received palliative radiation to her mediastinum and ribs. Because of disease progression, she subsequently received paclitaxel. Results. After paclitaxel administration, the patient became acutely dyspneic. A subsequent chest X‐ray revealed a parenchymal opacity in a region that corresponded with the patient's radiation portal. She also developed a severe skin reaction in the previously treated electron field. Conclusions. This is one of few reported cases of recall dermatitis from paclitaxel and is also suggestive of recall pneumonitis, a phenomenon previously unreported to the authors' knowledge. Given paclitaxel's ability to function as a radiosensitizer, this response is not unexpected. As the frequency of paclitaxel administration increases, its potential as a radiation sensitizer and radiation recall should be considered. Cancer 1995;76: 1069–72. Copyright © 1995 American Cancer Society
CITATION STYLE
Schweitzer, V. G., Juillard, G. J. F., Bajada, C. L., & Parker, R. G. (1995). Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel. Cancer, 76(6), 1069–1072. https://doi.org/10.1002/1097-0142(19950915)76:6<1069::AID-CNCR2820760623>3.0.CO;2-7
Mendeley helps you to discover research relevant for your work.